These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38288642)

  • 1. Deep-learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy.
    Huang CY; Chang RF; Lin CY; Hsieh MS; Liao PC; Wang YJ; Kao YC; Porta L; Lin PY; Lee CC; Lee YH
    Histopathology; 2024 May; 84(6):983-1002. PubMed ID: 38288642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
    Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
    Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
    Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
    AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.
    Chae BJ; Lee A; Song BJ; Jung SS
    World J Surg Oncol; 2009 Oct; 7():77. PubMed ID: 19852801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
    Renshaw AA; Gould EW
    Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
    Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY
    Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis.
    Harvey JM; Sterrett GF; Frost FA
    Pathology; 2002 Oct; 34(5):410-6. PubMed ID: 12408338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type of Architecture, Presence of Punctate Necrosis, and Extent of Involvement in Atypical Ductal Hyperplasia Can Predict the Diagnosis of Breast Carcinoma on Excision: A Clinicopathologic Study of 143 Cases.
    Zhang C; Wang EY; Liu F; Ruhul Quddus M; James Sung C
    Int J Surg Pathol; 2021 Oct; 29(7):716-721. PubMed ID: 33881947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning-based image analysis for accelerating the diagnosis of complicated preneoplastic and neoplastic ductal lesions in breast biopsy tissues.
    Sato S; Maki S; Yamanaka T; Hoshino D; Ota Y; Yoshioka E; Kawachi K; Washimi K; Suzuki M; Ohkubo Y; Yokose T; Yamashita T; Ohtori S; Miyagi Y
    Breast Cancer Res Treat; 2021 Aug; 188(3):649-659. PubMed ID: 33934277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort study.
    Hsieh YC; Lo C; Lee YH; Chien N; Lu TP; Tsai LW; Wang MY; Kuo WH; Chang YC; Huang CS
    World J Surg Oncol; 2023 Feb; 21(1):48. PubMed ID: 36804000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
    Tanaka K; Masuda N; Hayashi N; Sagara Y; Hara F; Kadoya T; Matsui A; Miyazaki C; Shien T; Tokunaga E; Hayashi T; Niikura N; Maeda S; Komoike Y; Bando H; Kanbayashi C; Iwata H
    Breast Cancer; 2021 Jul; 28(4):896-903. PubMed ID: 33599914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
    McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ
    Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underestimation Rate at MR Imaging-guided Vacuum-assisted Breast Biopsy: A Multi-Institutional Retrospective Study of 1509 Breast Biopsies.
    Verheyden C; Pages-Bouic E; Balleyguier C; Cherel P; Lepori D; Laffargue G; Doutriaux I; Jalaguier A; Poncelet E; Millet I; Thomassin-Naggara I; Taourel P
    Radiology; 2016 Dec; 281(3):708-719. PubMed ID: 27355898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep learning of mammogram images to reduce unnecessary breast biopsies: a preliminary study.
    Liu C; Sun M; Arefan D; Zuley M; Sumkin J; Wu S
    Breast Cancer Res; 2024 May; 26(1):82. PubMed ID: 38790005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!
    Marques LC; Marta GN; de Andrade JZ; Andrade D; de Barros ACSD; Andrade FEM
    Eur J Surg Oncol; 2019 Jul; 45(7):1152-1155. PubMed ID: 30665684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
    Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
    Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision.
    Walters LL; Pang JC; Zhao L; Jorns JM
    Histopathology; 2015 Mar; 66(4):577-86. PubMed ID: 25231210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.
    Gomes DS; Porto SS; Balabram D; Gobbi H
    Diagn Pathol; 2014 Jun; 9():121. PubMed ID: 24948027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.